Beijing Biostar Pharmaceuticals Co., Ltd. Class H ( (HK:2563) ) has shared an announcement.
Beijing Biostar Pharmaceuticals Co., Ltd. has been included as a constituent of the Hang Seng Composite Index, effective from March 10, 2025. This inclusion is seen as a recognition of the company’s business performance and is expected to enhance its shareholder base, increase trading liquidity, and improve its investment value and reputation in the capital market.
More about Beijing Biostar Pharmaceuticals Co., Ltd. Class H
Beijing Biostar Pharmaceuticals Co., Ltd. is a company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. It focuses on the development and production of biopharmaceutical products.
YTD Price Performance: -15.43%
Average Trading Volume: 179,952
See more insights into 2563 stock on TipRanks’ Stock Analysis page.